tiprankstipranks
Advertisement
Advertisement

ZYME Stock Latest News

Zymeworks price target raised to $37 from $34 at Wells Fargo
The FlyZymeworks price target raised to $37 from $34 at Wells Fargo
19h ago
ZYME
Zymeworks Earns Buy Rating as Non-Dilutive Theravance Deal and Long-Duration YUPELRI Cash Flows Drive Price Target Up to $37
PremiumRatings
Zymeworks Earns Buy Rating as Non-Dilutive Theravance Deal and Long-Duration YUPELRI Cash Flows Drive Price Target Up to $37
19h ago
ZYME
Zymeworks price target raised to $37 from $35 at Citi
PremiumThe Fly
Zymeworks price target raised to $37 from $35 at Citi
20h ago
TBPH
ZYME
Zymeworks’ TBPH Acquisition Seen as Cash-Flow Accretive, Supports Buy Rating and Unchanged $34 Price Target
PremiumRatings
Zymeworks’ TBPH Acquisition Seen as Cash-Flow Accretive, Supports Buy Rating and Unchanged $34 Price Target
2d ago
ZYME
Morning Movers: Comcast surges after announcing spinoff of NBCUniversal
PremiumThe Fly
Morning Movers: Comcast surges after announcing spinoff of NBCUniversal
2d ago
VZ
BTI
Zymeworks to Acquire Theravance in Strategic Merger
PremiumCompany AnnouncementsZymeworks to Acquire Theravance in Strategic Merger
2d ago
8K
ZYME
M&A News: Biotech Group Zymeworks Buys Lung Disease-Fighting Peer Theravance for $1B
Premium
Market News
M&A News: Biotech Group Zymeworks Buys Lung Disease-Fighting Peer Theravance for $1B
2d ago
TBPH
ZYME
Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash
Premium
The Fly
Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash
2d ago
TBPH
ZYME
Zymeworks to acquire Theravance Biopharma for $17.00 per share, or $929M
PremiumThe Fly
Zymeworks to acquire Theravance Biopharma for $17.00 per share, or $929M
2d ago
TBPH
ZYME
Zymeworks to acquire Theravance Biopharma for $17.00 per share
PremiumThe Fly
Zymeworks to acquire Theravance Biopharma for $17.00 per share
2d ago
TBPH
ZYME
Zymeworks Rated Buy on Undervalued Royalty Streams and High-Optionality Pipeline, Says Analyst
PremiumRatings
Zymeworks Rated Buy on Undervalued Royalty Streams and High-Optionality Pipeline, Says Analyst
2d ago
ZYME
Context Therapeutics selloff brings buying opportunity, says JonesResearch
PremiumThe Fly
Context Therapeutics selloff brings buying opportunity, says JonesResearch
15d ago
CNTX
ZYME
Zymeworks presents new clinical data on Phase 1 study of ZW191
PremiumThe FlyZymeworks presents new clinical data on Phase 1 study of ZW191
16d ago
ZYME
Zymeworks assumed with a Buy at Truist
Premium
The Fly
Zymeworks assumed with a Buy at Truist
22d ago
ZYME
Zymeworks and BeOne: Long‑Term Cancer Study Update Supports Durable Drug Story
Premium
Company Announcements
Zymeworks and BeOne: Long‑Term Cancer Study Update Supports Durable Drug Story
28d ago
ONC
ZYME
Analyst Reaffirms Buy on Ziihera’s HER2+ GEA Strength, Maintains $46 Price Target Ahead of 2026 PDUFA
PremiumRatings
Analyst Reaffirms Buy on Ziihera’s HER2+ GEA Strength, Maintains $46 Price Target Ahead of 2026 PDUFA
28d ago
ZYME
Citizens biotech analysts hold a dinnermeeting at ASCO
PremiumThe Fly
Citizens biotech analysts hold a dinnermeeting at ASCO
1M ago
AZN
LLY
Zymeworks Earnings Call Balances Promise and Risk
PremiumCompany Announcements
Zymeworks Earnings Call Balances Promise and Risk
1M ago
ZYME
Zymeworks authorizes share repurchase program of up to $125M
PremiumThe Fly
Zymeworks authorizes share repurchase program of up to $125M
2M ago
ZYME
Zymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity
PremiumCompany AnnouncementsZymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity
2M ago
8K
ZYME
Zymeworks Maintained at Buy as Analyst Highlights Cash Runway, Upcoming Catalysts and Reiterates $46 Price Target
Premium
Ratings
Zymeworks Maintained at Buy as Analyst Highlights Cash Runway, Upcoming Catalysts and Reiterates $46 Price Target
2M ago
ZYME
Zymeworks’ Earnings Call Balances Progress And Pressure
Premium
Company Announcements
Zymeworks’ Earnings Call Balances Progress And Pressure
2M ago
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >